![Stephen Brindle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Brindle
Chief Operating Officer at Engitix Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Nicholas Hawker | M | - |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | 13 years |
Giuseppe Mazza | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | 8 years |
Massimo Pinzani | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | 8 years |
David Bryon | M | - |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | 9 years |
Sonia Quaratino | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | 1 years |
Yiannis Ventikos | M | - |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | 13 years |
Gianluca Pisanello | M | - |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | - |
David Dally | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | 6 years |
Stephen Lloyd Frederick Hicks | M | - |
Oxsight Ltd.
![]() Oxsight Ltd. Miscellaneous Commercial ServicesCommercial Services Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom. | 8 years |
Philip Torr | M | - |
Oxsight Ltd.
![]() Oxsight Ltd. Miscellaneous Commercial ServicesCommercial Services Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom. | 8 years |
Albert Joseph Markus | M | 60 |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | - |
Rakesh Roshan | M | - |
Oxsight Ltd.
![]() Oxsight Ltd. Miscellaneous Commercial ServicesCommercial Services Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom. | - |
Eduardo Bravo | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | 4 years |
Jiangong Zhang | M | - |
Oxsight Ltd.
![]() Oxsight Ltd. Miscellaneous Commercial ServicesCommercial Services Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom. | - |
Jian Cao | M | 50 |
Oxsight Ltd.
![]() Oxsight Ltd. Miscellaneous Commercial ServicesCommercial Services Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom. | - |
Ronald Roy | M | - |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | - |
Robert Trezona | M | - |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | - |
Rajeev Sawhney | M | 67 |
Oxsight Ltd.
![]() Oxsight Ltd. Miscellaneous Commercial ServicesCommercial Services Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom. | 3 years |
Mike E. Platt | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | - |
Gianluca Rossetti | M | - |
Engitix Ltd.
![]() Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | 2 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Brindle
- Personal Network